Contract Extends and Expands Twelve-Year Relationship
Synygy Inc., the largest and most experienced provider of sales performance management (SPM) solutions, today announced that Daiichi Sankyo, Inc. (DSI), the U.S. pharmaceutical subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., has extended their 12-year relationship with Synygy for another five years with a new agreement for SPM software, sales compensation plan management outsourcing services, and a wide range of sales consulting services.
DSI utilizes Synygy’s industry-leading software and services to align sales plans with corporate goals, manage sales incentive compensation payments, and drive sales productivity and revenue.
“Synygy’s software and plan management services provide us with powerful tools to help drive sales performance,” said Peter Koniaris, Director of Sales Incentives for Daiichi Sankyo, Inc. “The software is scalable to manage our complex compensation plans for thousands of salespeople,and lets us adapt quickly to changes in the pharmaceutical sales environment. Synygy’s plan management team is responsive and delivers what they say they’ll deliver, when they say it’ll be delivered.”
Among its numerous recent accomplishments on behalf of Daiichi Sankyo, Inc., Synygy has:
- implemented new software for defining, setting, and maintaining objectives
- implemented new portal software that provides role-based reports and information to salespeople, sales managers, and sales analysts
- created a process for managing long-term incentives
- assisted in the setting of sales quotas
- managed various motivational sales contests
- provided on-demand staffing services to handle ad-hoc requests for expertise
“Daiichi Sankyo, Inc. has been a Synygy client since 1997,” said Mark A. Stiffler, Synygy president and CEO. “Tripling the size of its sales force over those dozen years, DSI has continued to rely upon Synygy for our superior SPM software, experience, and expertise. We are grateful for the deep level of engagement and partnership we have with DSI and look forward to continuing to work with them long into the future.”
About Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., which is a global pharmaceutical innovator. The headquarters company was established in 2005 from the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs for patients around the world. A central focus of Daiichi Sankyo’s research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes and acute coronary syndrome. Also important to the company is the discovery of new medicines in the areas of infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, visit www.dsi.com.
About Synygy
Synygy is the largest and most experienced provider of sales performance management (SPM) software and services. Synygy’s SPM solutions include: sales compensation (incentive compensation, rewards and recognition, and total compensation); sales communications (web portals, reports and dashboards, and analytics, alerts, and answers); sales goals (territories and channels, forecasting and pipeline analyses, and objectives and quotas); and sales processes (reviews, recruiting and training, data repository and data processes, and workflow processes). Based in Chester, Pennsylvania, with extensive operations in Europe and Asia, Synygy has achieved 18 continuous years of success. www.synygy.com
Contacts:
Synygy Inc.
Sue St. Laurent, 610-494-3300 x7259
st.laurent@synygy.com